Has Karen Campbell received payments from drug or device companies?

Yes. Drug and device makers reported $4,294 in general payments to Karen Campbell across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karen Campbell did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karen Campbell come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karen Campbell

Psychiatric/Mental Health · Bradenton, FLNPI 1265873178

Payments from drug & device makers

$4,294in general payments, 2019–2025

Across 50 payments — averaging $85.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$631
Alkermes, Inc.$547
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$462
Otsuka America Pharmaceutical, Inc.$344
Teva Pharmaceuticals USA, Inc.$303
Bayer$275
plus $2K from 16 others

What the payments were for

Food & beverage$4,24799%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	5	$631
Alkermes, Inc.	6	$547
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$462
Otsuka America Pharmaceutical, Inc.	4	$344
Teva Pharmaceuticals USA, Inc.	3	$303
Bayer	3	$275
E.r. Squibb & Sons, L.L.C.	2	$247
AbbVie	3	$215
Supernus Pharmaceuticals, Inc.	2	$186
Neurocrine Biosciences, Inc.	2	$163
Silk Road Medical, Inc.	2	$146
Phathom Pharmaceuticals, Inc.	1	$125
Pulmonx Corporation	1	$110
Boehringer Ingelheim	1	$102
Novo Nordisk	1	$94
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$83
Biohaven Pharmaceutical Holding Company Ltd.	1	$72
Lilly USA, LLC	1	$71
Amgen	1	$70
Tris Pharma Inc	1	$20
Boston Scientific	1	$14
Medline Industries LP	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,294 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BelsomraSuvorexant	12	$5,071
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	16	$622
Quetiapine Fumarate	13	$350

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Bradenton

Camille MarkhamBradenton$15K
Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →